Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2019-07-10 | Reverse | 1:9 |
| 2011-03-21 | Reverse | 1:20 |
| 2011-03-17 | Reverse | 1:20 |
Nephros, Inc. develops high-performance water filtration, pathogen detection, and renal products for medical and commercial markets, focusing on infection prevention, water quality, and renal disease treatment.

The SSU-H Ultrafilter is an FDA-cleared, point-of-use medical device using a 0.005-micron hollow-fiber membrane to remove bacteria, viruses, and endotoxins from water, supporting infection control in medical and commercial applications.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Product | $4.6M | — | $5.04M ▲ | $5.7M ▲ |
![]() | Royalty and Other Revenues | — | $384K | — | — |
Overall rating: B
| PEER | PRICE | |
|---|---|---|
SPRB | $60.78 | COMPARE |
OTLK | $0.64 | COMPARE |
ICCC | $9.94 | COMPARE |
OSTX | $1.64 | COMPARE |
NRXP | $3.55 | COMPARE |
DXR | $10.20 | COMPARE |
HOWL | $0.94 | COMPARE |
ONMD | $0.58 | COMPARE |